← Back to Patent Explorer
US3968236A Expired / Lapsed US ⏱️ 0.0 years remaining

2-Aminomethyl-5-hydroxy-4H-pyran-4-one and derivatives thereof

Assignee: Merck and Co Inc
•
Filing: 1975-01-22
•
Granted: 1976-07-06
•
Expires: 1995-01-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The 2-aminomethyl-5-hydroxy-4H-pyran-4-ones of the present invention are disclosed to have pharmaceutical utility as skeletal muscle relaxants. Also disclosed are processes for the preparation of such pyranones; pharmaceutical compositions comprising such compounds; and method of treatment comprising administering such compounds and compositions when a muscle relaxant effect is indicated.

Inventors

  • 👤 Joseph G. Atkinson
  • 👤 Joshua Rokach
  • 👤 Clarence S. Rooney

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 14:35
CPC Classifications
C; C07; C07D; C07D309/00; C07D309/34; C07D309/36; C07D309/40; A; A61; A61P; A61P21/00; A61P21/02

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 23 words
A compound having the structural formula: ##SPC3## wherein R is hydrogen or an α-amino acid acyl moiety or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 23 words
A compound having the structural formula: ##SPC3## wherein R is hydrogen or an α-amino acid acyl moiety or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 9 words
A compound according to claim 1 which is 2-aminomethyl-5-hydroxy-4H-pyran-4-one.
Claim 4
Dependent Claim 9 words
A compound according to claim 1 which is 2-amino-N-[(5-hydroxy-4H-pyran-4-on-2-yl)methyl]acetamide.
Claim 5
Dependent Claim 9 words
A compound according to claim 1 which is 2-amino-N-[(5-hydroxy-4H-pyran-4-on-2-yl)methyl]propionamide.
Claim 6
Dependent Claim 41 words
A pharmaceutical composition comprising a therapeutically effective amount in unitary dosage form of a compound having the formula: ##SPC4## wherein R is hydrogen or an α-amino acid acyl moiety or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier therefor.
Claim 7
Dependent Claim 41 words
A pharmaceutical composition comprising a therapeutically effective amount in unitary dosage form of a compound having the formula: ##SPC4## wherein R is hydrogen or an α-amino acid acyl moiety or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier therefor.
Claim 8
Independent Claim 45 words
A method of treatment of skeletal muscle hyperactivity comprising administering to a patient in need of such treatment a therapeutically effective amount of a compound having the formula: ##SPC5## wherein R is hydrogen or an α-amino acid acyl moiety or a pharmaceutically acceptable salt thereof.
Claim 9
Independent Claim 45 words
A method of treatment of skeletal muscle hyperactivity comprising administering to a patient in need of such treatment a therapeutically effective amount of a compound having the formula: ##SPC5## wherein R is hydrogen or an α-amino acid acyl moiety or a pharmaceutically acceptable salt thereof.

References Cited (Backward Citations)

US2865930A Cited
US2918402A Cited
US3029256A Cited
US3008971A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-07-06 1980-01-05 1980-07-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-07-06 1984-01-05 1984-07-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-07-06 1988-01-05 1988-07-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag